The Value of Anti-Angiogenic Treatments in PMP

There is a lot of evidence to suggest anti-angiogenic treatment (treatments that stop new blood vessels from growing) might be helpful in treatment for Pseudomyxoma peritonei. A new paper from the Flatmark Translational Cancer Therapy team suggests that angiogenesis may be a larger factor in PMP progression than previously thought. Although research is still in the early stages, this research suggests that the potential for anti-angiogenic treatment warrants further study.

The new paper may be read here.

Yvonne
Andersson
Karianne Giller
Fleten
Torveig Weum
Abrahamsson
Kjersti
Flatmark